Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure

被引:27
|
作者
Samouilidou, E
Grapsa, E
机构
[1] Alexandra Hosp, Biochem Dept, GR-11528 Athens, Greece
[2] Alexandra Hosp, Renal Unit, GR-11528 Athens, Greece
关键词
hemodialysis; peritoneal dialysis; total antioxidant capacity; malonaldehyde; 4-hydroxyalkenals;
D O I
10.1159/000070691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dialysis is associated with an impairment of antioxidant defense and an overproduction of oxidative stress markers. This study focuses on the comparison of plasma total antioxidant capacity (TAC) and lipid peroxidation products in patients on hemodialysis (HD) before and after treatment and in peritoneal dialysis (PD) patients. Plasma TAC, malonaldehyde (MDA), and 4-hydroxyalkenal concentrations were measured in 31 HD patients, in 24 PD patients, and in 17 normal controls (NC). It was found that before HD, TAC and MDA levels were higher than those in the NC (p < 0.001). After HD, these levels decreased significantly but were higher than in NC and lower than in PD patients (p < 0.001). The levels of 4-hydroxyalkenals were elevated in patients as compared with NC, but did not differ between HD and PD patients. The MDA concentrations correlated positively with the TAC in the patients. It is concluded that the oxidative status of patients on HD is similar to that of patients on PD and that the susceptibility to oxidative stress is strongly related to the levels of MDA produced in plasma. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 50 条
  • [41] End-stage renal failure due to total uterine prolapse
    Sanai, T
    Yamashro, Y
    Nakayama, M
    Uesugi, N
    Kubo, N
    Iguchi, A
    UROLOGY, 2006, 67 (03) : 622.e5 - 622.e7
  • [42] Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease
    Kanbay, M.
    Bavbek, N.
    Delibasi, T.
    Koca, C.
    Kaya, A.
    Altay, M.
    Akcay, A.
    Duranay, M.
    Yigitoglu, R.
    RENAL FAILURE, 2007, 29 (03) : 309 - 313
  • [43] TREATMENT OF END-STAGE RENAL-FAILURE BY INTEGRATED DIALYSIS AND TRANSPLANTATION
    MATHEW, TH
    MEDICAL JOURNAL OF AUSTRALIA, 1974, 2 (13) : 492 - 496
  • [44] Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients
    Cohen, G
    Rudnicki, M
    Schmaldienst, S
    Hörl, WH
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (05) : 879 - 883
  • [45] Not beginning chronic dialysis in patients with end-stage renal disease
    Garcia, MC
    Jornet, AR
    Ponz, E
    Almirall, J
    NEFROLOGIA, 1997, 17 (05): : 411 - 417
  • [46] Dialysis for Patients With End-stage Renal Disease Who Are Homeless
    Novick, Tessa K.
    Gadegbeku, Crystal A.
    Crews, Deidra C.
    JAMA INTERNAL MEDICINE, 2018, 178 (12) : 1581 - 1582
  • [47] Cancer Among End-Stage Renal Disease Patients on Dialysis
    Loy, En Yun
    Choong, Hui Lin
    Chow, Khuan Yew
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2013, 42 (12) : 640 - 645
  • [48] Dialysis Therapies in Older Patients with End-Stage Renal Disease
    Malavade, Tuschar
    Sokwala, Ahmed
    Jassal, Sarbjit Vanita
    CLINICS IN GERIATRIC MEDICINE, 2013, 29 (03) : 625 - +
  • [49] Cardiac surgery in patients with end-stage renal disease on dialysis
    Back, Caroline
    Hornum, Mads
    Moller, Christian Joost Holdflod
    Olsen, Peter Skov
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2017, 51 (06) : 334 - 338
  • [50] Total Bilirubin in Prognosis for Mortality in End-Stage Renal Disease Patients on Peritoneal Dialysis Therapy
    Yang, Tsung-Lin
    Lin, Yi-Chun
    Lin, Yen-Chung
    Huang, Chun-Yao
    Chen, Hsi-Hsien
    Wu, Mai-Szu
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12):